Skip to main content
logo
J-Pharma Co., Ltd. (TYO:520A)
Japan flag Japan · Delayed Price · Currency is JPY
405.00
+7.00 (1.76%)
Oct 9, 2026, 3:30 PM JST

J-Pharma Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24
Market Capitalization
7,31512,998--
Market Cap Growth
----
Enterprise Value
3,58710,696--
Last Close Price
398.00729.00--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24
PB Ratio
1.642.97--
P/TBV Ratio
1.642.97--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24
Net Debt / Equity Ratio
-1.02-1.02-0.97-1.13
Net Debt / EBITDA Ratio
1.201.201.440.62
Net Debt / FCF Ratio
1.981.981.360.76
Quick Ratio
11.9011.905.135.49
Current Ratio
12.5712.576.285.96
Return on Equity (ROE)
-73.01%-73.01%-90.09%-
Return on Assets (ROA)
-60.88%-60.88%-49.08%-
Return on Capital Employed (ROCE)
-84.60%-84.60%-66.40%-171.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24
Earnings Yield
-34.31%-18.98%--
FCF Yield
-31.34%-17.33%--
Buyback Yield / Dilution
--55.23%-29.92%-